blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2140862

EP2140862 - Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.11.2014
Database last updated on 28.06.2024
Most recent event   Tooltip14.11.2014Application deemed to be withdrawnpublished on 17.12.2014  [2014/51]
Applicant(s)For all designated states
H. Lundbeck A/S
Ottiliavej 9
2500 Valby-Copenhagen / DK
[2010/01]
Inventor(s)01 / Blackburn, Thomas P.
1 Fourteenth Street Apt. 412
Hoboken NJ 07030 / US
02 / Konkel, Michael
121 Park Ave.
La Crosse, WI 54601 / US
03 / Boteju, Lakmal W.
39 Grissing Court
Cedar NJ 07009 / US
04 / Talisman, Ian Jamie
326 West 87th Street Apt 1F
New York NY 10024 / US
05 / Wetzel, John M.
16-08 Well Drive
Fairlawn NJ 07410 / US
06 / Packiarajan, Mathivanaan
275 Madison Avenue Apt. 2
Saddle Brook NJ 07663 / US
07 / Chen, Heidi
376 Newtown Road
Wyckoff NJ 07481 / US
08 / Jimenez, Hermo
80 Clarendon Pl. Apt. 10-A
Hackensack NJ 07601 / US
09 / Lagu, Bharat
41 Fisher Drive
Hillsborough NJ 08844 / US
10 / Lim, Kitae
24 King Street Apt. 7
New York NY 10014 / US
11 / Noble, Stewart
Kalypsys, Inc. 10420 Water Wateridge Circle
San Diego, CA 92121 / US
 [2010/14]
Former [2010/01]01 / Blackburn, Thomas P.
1 Fourteenth Street Apt. 412
Hoboken NJ 07030 / US
02 / Konkel, Michael
69 MacArthur Avenue
Garfield NJ 07026 / US
03 / Boteju, Lakmal W.
39 Grissing Court
Cedar NJ 07009 / US
04 / Talisman, Ian Jamie
326 West 87th Street Apt 1F
New York NY 10024 / US
05 / Wetzel, John M.
16-08 Well Drive
Fairlawn NJ 07410 / US
06 / Packiarajan, Mathivanaan
275 Madison Avenue Apt. 2
Saddle Brook NJ 07663 / US
07 / Chen, Heidi
376 Newtown Road
Wyckoff NJ 07481 / US
08 / Jimenez, Hermo
80 Clarendon Pl. Apt. 10-A
Hackensack NJ 07601 / US
09 / Lagu, Bharat
41 Fisher Drive
Hillsborough NJ 08844 / US
10 / Lim, Kitae
24 King Street Apt. 7
New York NY 10014 / US
11 / Noble, Stewart
75 West Honeysuckle Road
Lake Forest IL 60045 / US
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2010/01]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date09010004.131.01.2002
[2010/01]
Priority number, dateUS2001077534131.01.2001         Original published format: US 775341
[2010/01]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2140862
Date:06.01.2010
Language:EN
[2010/01]
Type: A3 Search report 
No.:EP2140862
Date:17.02.2010
[2010/07]
Search report(s)(Supplementary) European search report - dispatched on:EP18.01.2010
ClassificationIPC:A61K31/00, A61K31/407, A61K31/506, C07D209/40, C07D239/50, C07D401/04, C07D401/06, C07D401/12, C07D401/14, C07D403/04, C07D403/12, C07D405/12, C07D405/14, C07D409/04, C07D409/06, C07D409/12, C07D409/14, C07D413/04, C07D413/06, C07D417/12, A61P25/24, A61P25/22
[2010/01]
CPC data not yet available
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2010/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RO11.08.2010
SI11.08.2010
TitleGerman:Verwendung von GAL3-Rezeptor-Antagonisten zur Behandlung von Depression und/oder Angstzuständen und für solche Verfahren nützliche Verbindungen[2010/01]
English:Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods[2010/01]
French:Utilisation d'antagonistes du recepteur GAL3 dans le traitement de la dépression et/ou de l'anxiété et composés utiles dans de telles méthodes[2010/01]
Examination procedure05.08.2010Amendment by applicant (claims and/or description)
11.08.2010Examination requested  [2010/39]
03.03.2011Despatch of a communication from the examining division (Time limit: M06)
12.09.2011Reply to a communication from the examining division
12.02.2013Despatch of a communication from the examining division (Time limit: M04)
20.06.2013Reply to a communication from the examining division
04.03.2014Despatch of a communication from the examining division (Time limit: M04)
15.07.2014Application deemed to be withdrawn, date of legal effect  [2014/51]
13.08.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/51]
Parent application(s)   TooltipEP02714918.6  / EP1363638
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020714918) is  10.06.2010
Fees paidRenewal fee
03.08.2009Renewal fee patent year 03
03.08.2009Renewal fee patent year 04
03.08.2009Renewal fee patent year 05
03.08.2009Renewal fee patent year 06
03.08.2009Renewal fee patent year 07
03.08.2009Renewal fee patent year 08
30.12.2009Renewal fee patent year 09
14.01.2011Renewal fee patent year 10
25.01.2012Renewal fee patent year 11
10.01.2013Renewal fee patent year 12
Penalty fee
Additional fee for renewal fee
31.01.201413   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DX]WO9815570  (SYNAPTIC PHARMA CORP [US], et al) [DX] 1-14 * abstract * * page 6, line 21 - page 7, line 7 * * page 10, line 35 - page 11, line 1 * * page 13, line 3 - line 21 * * page 47, line 18 - line 32 * * page 64, line 11 - line 35 * * page 70, line 28 - page 71, line 6 * * page 71, line 28 - line 36 * * page 75, line 24 - page 76, line 1 * * page 124; table 2 * * claims 118-121,144-147 *;
 [A]JPH11158073  (TAKEDA CHEMICAL INDUSTRIES LTD) [A] * abstract * * page 27, compound 49 *;
 [A]WO0076980  (YAMANOUCHI PHARMA CO LTD [JP], et al) [A] * abstract ** page 32, compounds 4-1 and 4-2 *;
 [A]  - BARTFAI TAMAS ET AL, "Galanin receptor ligands as potential therapeutic agents in depression and neurodegeneration", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, (1995), vol. 30, no. SUPPL., ISSN 0223-5234, pages 163S - 174S, XP008116736 [A] 1-14 * the whole document *
 [A]  - WEISS J M ET AL, "Galanin: a significant role in depression?", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 21 DEC 1998, (19981221), vol. 863, ISSN 0077-8923, pages 364 - 382, XP002562085 [A] 1-14 * abstract *

DOI:   http://dx.doi.org/10.1111/j.1749-6632.1998.tb10707.x
 [A]  - MOLLER CHRISTIAN ET AL, "Anxiogenic-like action of galanin after intra-amygdala administration in the rat", NEUROPSYCHOPHARMACOLOGY, (199910), vol. 21, no. 4, ISSN 0893-133X, pages 507 - 512, XP002562086 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0893-133X(98)00102-X
 [A]  - ZAM A ET AL, "Synthesis and pharmacological activities of Mannich bases using indole-2,3-dione/3-phenylimino-2-indolinone as amine moiety", JOURNAL OF THE INSTITUTION OF CHEMISTS (INDIA), CALCUTTA, IN, (19960101), vol. 68, no. 4, ISSN 0020-3254, pages 114 - 116, XP008115350 [A] * the whole document *
 [A]  - SEN GUPTA A K ET AL, "Synthesis of indole derivatives as potential biodynamic agents: Part II: 1,5-Disubstituted 3-(5-aryl-1,3,4-oxadiazol-2-yl)-iminoindolin-2 ones as possible antibacterial and CNS active agents", CURRENT SCIENCE, INDIAN ACADEMY OF SCIENCES, IN, (19821205), vol. 51, no. 23, ISSN 0011-3891, pages 1100 - 1103, XP008115354 [A] * table 1 * * page 1101, column R * * table 2 *
    [ ] - SEN GUPTA, A. K. ET AL, "Synthesis of indole derivatives as potential biodynamic agents: Part II: 1,5-Disubstituted 3-(5-aryl-1,3,4-oxadiazol-2-yl)-iminoindolin-2-ones as possible antibacterial and CNS active agents", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1983:83236, URL: STN, XP002557738 [ ] * abstract *
ExaminationEP0629615
    - SEN GUPTA A K ET AL, "Synthesis of indole derivatives as potential biodynamic agents: Part II: 1,5-Disubstituted 3-(5-aryl-1,3,4-oxadiazol-2-yl)-iminoindolin-2-ones as possible antibacterial and CNS active agents", CURRENT SCIENCE, INDIAN ACADEMY OF SCIENCES, IN, (19821205), vol. 51, no. 23, ISSN 0011-3891, pages 1100 - 1103, XP008115354
    - REGISTRY, (20001117), XP002557739
    - REGISTRY, (20001122), XP002557740
    - REGISTRY, (20001117), XP002557741
    - REGISTRY, (20001117), XP002557742
by applicantWO9815570
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.